Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Compounds that upregulate LDL receptor expression disclosed in patent literature

Sep. 6, 2002

Orally bioavailable and safe SGLT2 inhibitors useful for diabetes and related disorders

Sep. 6, 2002

New agents for diabetes and hyperlipidemia designed by Takeda scientists

Sep. 6, 2002

New class of PTP1B inhibitors discovered at Morphochem

Sep. 6, 2002

Lexicon Genetics initiates small molecule discovery in obesity

Sep. 6, 2002

Benzothiazepines from Banyu increase GLP-1

Sep. 5, 2002

IK-264 reduces body weight by suppressing appetite

Sep. 5, 2002

New data on NN-2211 in the treatment for type 2 diabetes presented at the EASD meeting

Sep. 5, 2002

Beneficial effects on beta-cell function reported for the new potassium channel opener NN-414

Sep. 5, 2002

Lilly and EFSD announce diabetes research partnership

Sep. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...